SOLVAY PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
SOLVAY PHARMACEUTICALS, INC. holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 26 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ROWASA, BALNEOL, GRALISE, HYDROCIL, and CORTENEMA. The owner is based in MARIETTA, GA.
901 SAWYER ROAD
MARIETTA, GA 30062
Showing of trademarks Trademarks
Trademark Classifications
SOLVAY PHARMACEUTICALS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does SOLVAY PHARMACEUTICALS, INC. have?
SOLVAY PHARMACEUTICALS, INC. has 28 U.S. trademarks filed with the USPTO. Of these, 6 registered, 10 abandoned, 12 cancelled.
What trademark classes does SOLVAY PHARMACEUTICALS, INC. file in?
SOLVAY PHARMACEUTICALS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 6 (Metal Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SOLVAY PHARMACEUTICALS, INC.'s most well-known trademarks?
SOLVAY PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as ROWASA, BALNEOL, GRALISE, HYDROCIL, and CORTENEMA. These are among 6 currently registered trademarks in the portfolio.
What is SOLVAY PHARMACEUTICALS, INC.'s trademark registration success rate?
SOLVAY PHARMACEUTICALS, INC. has a 21% trademark registration rate, with 6 out of 28 resolved applications resulting in successful registration. Currently, 0 applications are pending review.